RxDoctor Payments Data

Anna Marjan, MD

Vascular Surgery · Robbinsdale, MNNPI 1346621919

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.7% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Medtronic at 35.8% of the total. Reporting peaked in 2019 at $766 and has fallen 67.1% since, to $252 in 2025. That places this record below the midpoint for vascular surgery clinicians in MN, where the typical reported total is $3,317.

$3,365in general payments, 2019–2025

Across 42 payments — averaging $80.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • W. L. Gore & Associates, Inc.$762
  • Penumbra, Inc.$687
  • Abbott$230
  • Bolton Medical Inc$160
  • Cook Medical LLC$103
  • plus $216 from 5 others

What the payments were for

  • Travel & lodging$441%
  • Food & beverage$3,18795%
  • Education$1334%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,365 in reported general payments places this provider in the 50th percentile of 84 vascular surgery providers in Minnesota.

See all vascular surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$72,846
Medicare patients
164
Services billed
353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban11$10,668
EliquisApixaban14$9,427
Atorvastatin Calcium77$1,315
ClopidogrelClopidogrel Bisulfate50$734
Enoxaparin Sodium14$578
Cilostazol24$224
Chlorhexidine Gluconate13$63
Mupirocin11$60

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Robbinsdale

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →